| Per-and polyfluoroalkyl substance exposure combined with high-fat diet supports prostate cancer progression OB Imir, AZ Kaminsky, QY Zuo, YJ Liu, R Singh, MJ Spinella, J Irudayaraj, ... Nutrients 13 (11), 3902, 2021 | 23 | 2021 |
| Combined targeting of estrogen receptor alpha and XPO1 prevent Akt activation, remodel metabolic pathways and induce autophagy to overcome tamoxifen resistance E Kulkoyluoglu-Cotul, BP Smith, K Wrobel, Y Chen Zhao, KLA Chen, ... Cancers 11 (4), 479, 2019 | 23 | 2019 |
| Targeting metabolic adaptations in the breast cancer–liver metastatic niche using dietary approaches to improve endocrine therapy efficacy Q Zuo, AN Mogol, YJ Liu, A Santaliz Casiano, C Chien, J Drnevich, ... Molecular Cancer Research 20 (6), 923-937, 2022 | 16 | 2022 |
| Per-and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells WY Hu, R Lu, DP Hu, OB Imir, Q Zuo, D Moline, P Afradiasbagharani, ... Biochemical pharmacology 197, 114902, 2022 | 15 | 2022 |
| Combined targeting of estrogen receptor alpha and exportin 1 in metastatic breast cancers EK Cotul, Q Zuo, A Santaliz-Casiano, OB Imir, AN Mogol, E Tunc, ... Cancers 12 (9), 2397, 2020 | 15 | 2020 |
| NAD+ Metabolism Generates a Metabolic Vulnerability in Endocrine-Resistant Metastatic Breast Tumors in Females AN Mogol, Q Zuo, JY Yoo, AZ Kaminsky, OB Imir, Y Landesman, ... Endocrinology 164 (6), bqad073, 2023 | 10 | 2023 |
| Coexistence of chronic hyperalgesia and multilevel neuroinflammatory responses after experimental SCI: a systematic approach to profiling neuropathic pain L Wang, MA Gunduz, AT Semeano, EC Yılmaz, FAH Alanazi, OB Imir, ... Journal of Neuroinflammation 19 (1), 264, 2022 | 8 | 2022 |
| Targeting metabolic vulnerabilities of endocrine resistant breast cancers using XPO1 and NAMPT inhibition Q Zuo, A Mogol, O Imir, Y Landesman, ZM Erdogan Cancer Research 81 (13_Supplement), 738-738, 2021 | 1 | 2021 |
| The effects of per-and polyfluoroalkyl substances (PFAS) and high fat diet on metabolism, reproductive health & prostate cancer progression OB Imir University of Illinois at Urbana-Champaign, 2021 | | 2021 |
| Metastatic organ-specific changes in ERα and XPO1 signaling and metabolic adaptations dictate the therapy responses in endocrine resistant breast cancers Q Zuo, EK Cotul, A Santaliz-Casiano, OB Imir, E Tunc, C Mao, DJ Shapiro, ... Cancer Research 80 (16_Supplement), 5675-5675, 2020 | | 2020 |
